psychedelics investing Lobe Sciences, Ltd. Announces Amendment to the Acquisition of Altemia & Company
psychedelics investing Lobe Sciences Announces Additional Details Regarding the Acquisition of Altemia & Company
psychedelics investing Lobe Sciences Announces Commercial Distribution Agreement With Pentec Health for US Launch of Altemia
psychedelics investing Lobe Sciences to Present at Sequire Cannabis & Psychedelics Conference April 5, 2023
psychedelics investing Lobe Sciences Ltd. Announces That The Drug Enforcement Administration Has Issued The Initial 2023 Quota Allowing Export Of L-130
psychedelics investing Chronic Cluster Headaches No More: The Promise Of Lobe Sciences' At-Home Psychedelic Treatments Without The Trip!
psychedelics investing Lobe Sciences Ltd. Announces Exclusive Collaboration with Quality Chemical Laboratories LLC
psychedelics investing Lobe Sciences, Ltd. Announces USD$250,000 Convertible Note Financing and Warrant Issuance
Kobo Resources Intersects 21.5 m at 1.14 g/t Au and 20.0 m at 1.41 g/t Au at the Jagger Zone and Files FY 2025 Financial Results
Freegold Achieves over 90% Gold Recovery Using BIOX® and greater than 92% Gold Recovery using POX - Additional Metallurgical Work Remains Ongoing
Silver Crown Royalties Executes LOI with Kuya Silver for a Silver Royalty on the Bethania Silver Project
